29947-24-8 Usage
General Description
2-Bromo-4,5-dimethyl-1,3-thiazole is a synthetic, organic chemical compound categorized under the chemical class of thiazoles. The IUPAC name for the compound is 2-Bromo-4,5-dimethyl-1,3-thiazole. It is generally used in the preparation of various pharmaceutical drugs or as an intermediate in organic synthesis. It has a molecular formula of C5H6BrNS and a molecular weight of 194.08 g/mol. The compound appears as a crystalline solid and is stable under various environmental conditions. However, it may present some hazards, such as an irritating effect on eyes, skin, or respiratory system upon exposure. This chemical requires careful handling and disposal following the guidelines of local and federal regulations.
Check Digit Verification of cas no
The CAS Registry Mumber 29947-24-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,9,4 and 7 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 29947-24:
(7*2)+(6*9)+(5*9)+(4*4)+(3*7)+(2*2)+(1*4)=158
158 % 10 = 8
So 29947-24-8 is a valid CAS Registry Number.
29947-24-8Relevant articles and documents
-
Kurkjy,Brown
, p. 6260 (1952)
-
TRICYCLIC COMPOUNDS AS MATRIX METALLOPROTEINASE INHIBITORS
-
Page/Page column 86, (2010/09/17)
The present teachings relate to compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein R1, R2, R3, R4, X, and Y are as defined herein. The present teachings also provide methods of making the compounds of formula I and methods of inhibiting matrix metalloproteinases, in particular, MMP-12, that may be involved in pathological disorders found in mammals, including a human.
CARBACEPHEM β-LACTAM ANTIBIOTICS
-
Page/Page column 85, (2009/05/30)
Carbacephem β-lactam antibiotics having the following chemical structures (I) and (II) are disclosed, including stereoisomers, pharmaceutically acceptable salts, esters and prodrugs thereof, wherein Ar2, R1, R2 and R3 are as defined herein. The compounds are useful for the treatment of bacterial infections, in particular those caused by methicillin-resistant Staphylococcus spp.
